60 Degrees Pharmaceuticals Statistics
Share Statistics
60 Degrees Pharmaceuticals has 2.30M shares outstanding. The number of shares has increased by -79.25% in one year.
| Shares Outstanding | 2.30M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 23.39% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.86M |
| Failed to Deliver (FTD) Shares | 4.84K |
| FTD / Avg. Volume | 0.83% |
Short Selling Information
The latest short interest is 37.30K, so 1.62% of the outstanding shares have been sold short.
| Short Interest | 37.30K |
| Short % of Shares Out | 1.62% |
| Short % of Float | 2% |
| Short Ratio (days to cover) | 0.34 |
Valuation Ratios
The PE ratio is -12.87 and the forward PE ratio is -0.55.
| PE Ratio | -12.87 |
| Forward PE | -0.55 |
| PS Ratio | 191.16 |
| Forward PS | 1 |
| PB Ratio | 9.95 |
| P/FCF Ratio | -10.4 |
| PEG Ratio | n/a |
Enterprise Valuation
60 Degrees Pharmaceuticals Inc. has an Enterprise Value (EV) of 3.96M.
| EV / Earnings | -1.05 |
| EV / Sales | 15.6 |
| EV / EBITDA | -2.77 |
| EV / EBIT | -0.77 |
| EV / FCF | -0.85 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.55 |
| Quick Ratio | 2.39 |
| Debt / Equity | 0.03 |
| Total Debt / Capitalization | 3.16 |
| Cash Flow / Debt | -28.57 |
| Interest Coverage | -2.25 |
Financial Efficiency
Return on equity (ROE) is -0.77% and return on capital (ROIC) is -103.7%.
| Return on Equity (ROE) | -0.77% |
| Return on Assets (ROA) | -0.48% |
| Return on Capital (ROIC) | -103.7% |
| Revenue Per Employee | 84.52K |
| Profits Per Employee | -1.26M |
| Employee Count | 3 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.02 |
Taxes
| Income Tax | 250 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -92.46% in the last 52 weeks. The beta is 5.27, so 60 Degrees Pharmaceuticals 's price volatility has been higher than the market average.
| Beta | 5.27 |
| 52-Week Price Change | -92.46% |
| 50-Day Moving Average | 1.16 |
| 200-Day Moving Average | 2.01 |
| Relative Strength Index (RSI) | 39.26 |
| Average Volume (20 Days) | 582.24K |
Income Statement
In the last 12 months, 60 Degrees Pharmaceuticals had revenue of 253.57K and earned -3.77M in profits. Earnings per share was -0.95.
| Revenue | 253.57K |
| Gross Profit | -220.98K |
| Operating Income | -5.15M |
| Net Income | -3.77M |
| EBITDA | -1.43M |
| EBIT | -5.15M |
| Earnings Per Share (EPS) | -0.95 |
Balance Sheet
The company has 2.14M in cash and 172.67K in debt, giving a net cash position of 1.97M.
| Cash & Cash Equivalents | 2.14M |
| Total Debt | 172.67K |
| Net Cash | 1.97M |
| Retained Earnings | -32.58M |
| Total Assets | 7.42M |
| Working Capital | 5.58M |
Cash Flow
In the last 12 months, operating cash flow was -4.54M and capital expenditures -115.89K, giving a free cash flow of -4.66M.
| Operating Cash Flow | -4.54M |
| Capital Expenditures | -115.89K |
| Free Cash Flow | -4.66M |
| FCF Per Share | -1.18 |
Margins
Gross margin is -87.15%, with operating and profit margins of -2.03K% and -1.49K%.
| Gross Margin | -87.15% |
| Operating Margin | -2.03K% |
| Pretax Margin | -1.50K% |
| Profit Margin | -1.49K% |
| EBITDA Margin | -562.58% |
| EBIT Margin | -2.03K% |
| FCF Margin | -1.84K% |
Dividends & Yields
SXTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -105.56% |
| FCF Yield | -225.06% |
Analyst Forecast
Currently there are no analyst rating for SXTP.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 12, 2024. It was a backward split with a ratio of 1:12.
| Last Split Date | Aug 12, 2024 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -8.55 |
| Piotroski F-Score | 6 |